Don M. Bailey
President and Chief Executive Officer
Mr. Bailey joined Questcor in May 2007 as Interim President, and was appointed to his current position in November 2007.
Chief Operating Officer
Before joining Questcor in March 2005, Mr. Cartt worked with a variety of specialty pharma and venture capital firms to identify and pursue licensing and development opportunities, as well as to assess start-up company concepts.
Executive Vice President & Chief Technical Officer
Dave Medeiros joined Questcor in June 2003 as Vice President, Manufacturing. Dave's experience includes management of manufacturing, inventory control, distribution, quality control, process development, and engineering functions in pharmaceutical, biotech, and medical device operating companies, and management of pharmaceutical contract manufacturers and testing laboratories.
Michael H. Mulroy
Executive Vice President, Chief Financial Officer and General Counsel
Mr. Mulroy joined Questcor in January 2011. From 2003 to 2011, Mr. Mulroy was employed by the law firm of Stradling Yocca Carlson & Rauth, where he served as a partner from 2004.
David Young Pharm.D., Ph.D.
Chief Scientific Officer
Before joining Questcor in October 2009, David Young served as Executive Director & President, U.S. Operations of AGI Therapeutics plc since 2006.
Senior Vice President, Corporate Strategic Development
Michael Aldridge joined Questcor in January 2013. From 2010 to 2012 Mr. Aldridge was CEO of Xenome Limited, a pain focused product development company and from 2003 to 2008 he was CEO of Peplin, Inc which developed a topical treatment for skin cancer.
Senior Vice President and Chief Compliance Officer
Ray Furey joined Questcor in October 2011. In his capacity as Vice President, Compliance & Chief Compliance Officer, he is responsible for our healthcare compliance program.
Senior Vice President, Commercial Operations
Eldon Mayer joined Questcor in July 2008 and most recently served as a management consultant providing marketing, business and strategy expertise, as well as guidance on operational and launch plans, for a variety of biotech and pharmaceutical clients.
Sian Bigora, Pharm.D.
Vice President, Regulatory Affairs
Before joining Questcor in November 2009, Sian Bigora served as Vice President, Clinical Research and Regulatory Affairs at AGI Therapeutics plc since 2007.
Gary S. Hogge, DVM, MS, Ph.D.
Vice President, Medical Affairs
Dr. Hogge originally joined Questcor as a Medical Affairs consultant in September 2011. He has worked for a variety of companies, including SmithKline Beecham, Pfizer, Maxim Pharmaceuticals, and Elan Pharmaceuticals in a variety of capacities with increased responsibility ranging from Research and Development, Clinical Development, Medical Affairs, and as Medical Director.
Vice President, Portfolio Strategy
Before joining Questcor in November 2010, Jim was the US Director for Healthcare Consulting at Datamonitor and prior to this was an independent consultant providing strategic marketing consulting services to early-stage biopharmaceutical companies.
Gregory F. Liposky
Vice President Contract Manufacturing
Gregory Liposky joined Questcor in July 2013 as Vice President Contract Manufacturing. Most recently, served as Vice President and General Manager for MedImmune, where he was responsible for leading their large scale mammalian cell culture facility.
Vice President, Neurology Sales
Darlene Romine joined Questcor in February 2012 and previously served as Vice President of Neurology Sales at BiogenIdec where she helped launch Avonex and Tysabri.